Hygea Healthcare (6078.HK): The hospital business continues to grow rapidly, and the repurchase of shares shows the company's confidence
Hygea Healthcare (6078.HK): The merger of epitaxial hospitals increases performance, endogenous revenue and profit growth are under pressure
Hygea Healthcare (06078.HK): The interim report is in line with expectations, and many projects under construction are progressing in an orderly manner
Hygea Healthcare (06078.HK): Academic strength steadily strengthens share repurchases and enhances confidence
Bocom Intl: Maintains a 'buy' rating on Hygeia Health (06078) with a target price reduced to 24.5 Hong Kong dollars.
Hygea Healthcare (6078.HK) 1H24 has steady operation, new hospital expansion and orderly implementation, and future share repurchases will accelerate the reduction of target prices
HYGEIA HEALTHCARE(6078.HK):1H24 RESULTS MISSED;MAY FOCUS ON SHARE BUYBACK INSTEAD OF M&A IN SHORT TERM
HYGEIA HEALTHCARE HOLDINGS CO. LIMITED(06078.HK):SOLID PERFORMANCE OF HOSPITAL BUSINESS
Hygea Healthcare (06078.HK): Rapid performance growth in the first half of 2024 and smooth progress in endogenous and epitaxial
Nomura Adjusts Hygeia Healthcare's Price Target to HK$50.70 From HK$58.20, Keeps at Buy
Nomura: Maintains a 'buy' rating for Hygeia Health (06078) and lowers the target price to HKD 50.7.
Hygea Healthcare (6078.HK): Performance is in line with expectations, and bed expansion is progressing steadily
Hygea Healthcare (6078.HK): Strong management resilience and gradual entry into the harvest period
GF Securities: Target price of HK$38.81 for a “buy” rating for Hygea Healthcare (06078)
Hygea Healthcare (6078.HK) 2023 performance review: Successful hospital acquisition and integration, optimistic about 24-year performance growth
Hygea (6078.HK): The release of bed capacity due to mergers and acquisitions of high-quality hospitals is expected to accelerate
Hygea Healthcare (06078.HK): Merger and acquisition integration benefits highlight regional advantages and further strengthen brand influence
Hygea Healthcare (6078.HK): FY23 meets expectations FY24 endogenous epitaxial drives high growth, and the operating conditions of the new hospital continue to improve
Hygea Healthcare (6078.HK): Endogenous growth combined with epitaxial expansion will maintain rapid growth in revenue
Hygea Healthcare (06078.HK) Hong Kong Stock Company Information Update Report: Rapid Performance Growth in 2023, Endogenous and External Growth Continues to Advance
No Data
No Data